How can single cell technology help predict treatment outcomes to develop targeted therapies?
Tapestri enables precision disease profiling and therapeutic characterization at the single-cell level to empower next-generation therapies.
Providing cancer researchers with the only single-cell technology that simultaneously measures single nucleotide variation (SNV), copy number variation (CNV), and protein data from the same cells. Our multi-omics platform connects genotype and phenotype in each cell, dissecting the architecture of tumors with unprecedented resolution.
